Skip to content
Subscribe
Newsletter
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Finding a Diagnosis
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Blog
Podcast
Product Guide
Career Quest
Research
Blog Post
Mallinckrodt Pharmaceuticals Releases Statement to DMD Community Announcing Discontinuation of Clinical Trials Program for DMD
By
MDA Staff
|
December 20, 2019
Blog Post
Amylyx Pharmaceuticals Announces Positive Results from Phase 2 Study of AMX0035 for Treatment of ALS
By
Jeanene Swanson
|
December 19, 2019
Blog Post
Santhera Pharmaceuticals Announces Publication of Positive Long-Term Results from Retrospective Study of Idebenone in DMD
By
Jeanene Swanson
|
December 18, 2019
Blog Post
Solid Biosciences Releases Letter to DMD Community Announcing Update on IGNITE DMD Trial, Resolution of Serious Adverse Event
By
MDA Staff
|
December 18, 2019
Blog Post
Wave Life Sciences Releases Letter to DMD Community Announcing Discontinuation of Clinical Trials Program for Therapies Amenable to Skipping Exons 51 and 53
By
MDA Staff
|
December 16, 2019
Blog Post
Kadimastem Announces Positive Interim Results from Phase 1/2a Study of AstroRx in ALS
By
Jeanene Swanson
|
December 5, 2019
Blog Post
FDA Accepts Roche Genentech’s NDA for Risdiplam for the Treatment of SMA
By
Jeanene Swanson
|
December 3, 2019
Blog Post
Zogenix Announces Positive Results from Pivotal Study of Investigational Treatment MT1621 for TK2 Deficiency
By
Jeanene Swanson
|
December 2, 2019
Blog Post
Santhera Pharmaceuticals Releases Letter to DMD Community Announcing Temporary Suspension of Enrollment in BreatheDMD Expanded Access Program
By
MDA Staff
|
November 26, 2019
Blog Post
Roche Genentech Announces Positive Results from Pivotal Study of Risdiplam in SMA Types 2 and 3
By
Jeanene Swanson
|
November 15, 2019
« Previous
1
…
15
16
17
18
19
…
26
Next »
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset